Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jul 15, 2026
PIMCO RAFI Dynamic Multi-Factor International Equity ETF (MFDX): A Rules-Based Approach to Developed Markets ex-U.S.

PIMCO RAFI Dynamic Multi-Factor International Equity ETF (MFDX): A Rules-Based Approach to Developed Markets ex-U.S.

Key Takeaways

  • MFDX provides diversified exposure to developed-market equities outside the United States through a rules-based, multi-factor strategy emphasizing value, quality, momentum, low volatility, and size factors.
  • The ETF held approximately 1,300 securities as of mid-2026, with the largest country allocations to Japan, the United Kingdom, Canada, and Switzerland, and top sector weights in industrials and financial services.
  • International developed-market equities have benefited from improving earnings momentum and attractive relative valuations compared to U.S. peers, though geopolitical tensions and energy price volatility have introduced intermittent headwinds.
  • MFDX's multi-factor design and broad diversification across countries and sectors provide a structurally resilient foundation, though the fund remains sensitive to currency fluctuations and shifts in global monetary policy.
  • Investor attention to AI-driven capital expenditure cycles, central bank rate trajectories, and energy supply dynamics will be critical in shaping the fund's performance environment through the remainder of 2026.

Overview of the MFDX ETF

Launched in August 2017 and managed by PIMCO, the PIMCO RAFI Dynamic Multi-Factor International Equity ETF seeks to track the RAFI Dynamic Multi-Factor Developed Ex-U.S. Index. The fund invests at least 80% of its total assets in the component securities of the underlying index, which is constructed using a rules-based methodology that dynamically allocates across five factor portfolios: value, low volatility, quality, momentum, and size. This smart-beta approach aims to capture excess returns while potentially reducing risk relative to less diversified strategies.

MFDX maintains a broadly diversified portfolio of approximately 1,300 holdings, with the top 10 positions accounting for roughly 8.8% of total assets — reflecting a low-concentration structure. The largest individual holdings include ASML Holding N.V., Novartis AG, Tokyo Electron Limited, Banco Santander S.A., Nestlé S.A., and Roche Holding AG. Sector allocations are led by industrials at roughly 19%, followed by financial services at approximately 16%, basic materials around 10%, and technology near 10%. Geographically, Japan represents the largest country exposure at about 26%, with the United Kingdom, Canada, Switzerland, France, and Germany rounding out the top exposures. The fund carries a net expense ratio of 0.39% and reported total net assets of approximately $456 million as of mid-2026. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the international equity space.

The Industry and Thematic Landscape

Developed international equity markets have navigated a complex environment through the first half of 2026. The global expansion has remained on solid footing, supported by resilient consumer spending and a powerful AI-driven capital expenditure cycle. However, geopolitical tensions — particularly the U.S.-Israeli military campaign against Iran and the effective closure of the Strait of Hormuz — have disrupted energy markets, pushed up inflation expectations, and forced markets to reassess the policy path for major central banks.

Against this backdrop, non-U.S. equities have attracted renewed attention from institutional allocators. Several factors underpin this interest: attractive relative valuations compared to U.S. stocks, improving earnings momentum across Europe and Japan, and a broadening of the global equity rally beyond U.S. large-cap technology names. Japan's ongoing corporate governance reforms continue to unlock shareholder value, while European defense spending commitments have brightened the region's long-term growth outlook. At the same time, persistent inflation and the possibility of additional monetary tightening by developed-market central banks have introduced periodic risk-off episodes, affecting international equity ETFs including MFDX.

Performance and Positioning Snapshot

MFDX has exhibited relatively range-bound behavior in recent months, reflecting the tug-of-war between supportive earnings trends and macroeconomic uncertainty. The fund's multi-factor design — blending value, quality, and low-volatility exposures — has provided a degree of downside cushion during risk-off episodes while still capturing upside participation during broad-based rallies in developed international markets.

The fund's heavy weighting toward industrials and financial services means it remains levered to global economic growth and capital expenditure trends. Holdings in semiconductor equipment leaders such as ASML and Tokyo Electron have benefited from the AI infrastructure buildout, while positions in European financials like Banco Santander and Societe Generale have been supported by a higher-for-longer interest rate environment. Conversely, the fund's exposure to basic materials and energy — through names like Glencore and Rio Tinto — has introduced sensitivity to commodity price fluctuations, which have been particularly volatile amid the Middle East energy supply disruption. Currency dynamics, especially the yen and euro against the U.S. dollar, have also influenced the ETF's performance, given that MFDX does not hedge its currency exposure.

Enhancing Analysis with AI Tools

For investors seeking to identify new opportunities across global equity markets, Tickeron's AI Screener provides an AI-powered stock and ETF discovery platform. The tool enables users to scan thousands of securities using a comprehensive range of criteria including technical indicators, fundamental metrics, volatility measures, AI-generated signals, market trends, price patterns, and customizable industry filters. By automating the screening process, the AI Screener helps investors surface trending securities, breakout candidates, and new trading ideas more efficiently than manual research alone. I find it particularly useful when monitoring multi-factor international ETFs like MFDX or exploring individual stock opportunities alongside broader market themes. The platform offers a streamlined approach to idea generation that complements traditional fundamental work.

2026 Outlook and Key Factors to Monitor

Looking ahead, several structural factors will likely influence MFDX's investment environment. The trajectory of global monetary policy remains front and center: with the Federal Reserve expected to remain on hold while other developed-market central banks navigate sticky inflation, the interest rate differential between the U.S. and other economies will continue to shape currency markets — a critical variable for an unhedged international equity fund.

The AI capex supercycle represents a powerful tailwind for MFDX's technology and industrial holdings, particularly the fund's exposure to semiconductor equipment manufacturers and industrial automation companies. However, the durability of this spending cycle and its ultimate return on investment will be closely scrutinized by markets. Additionally, the potential for a weakening U.S. dollar — cited by several major research institutions as a core conviction for the second half of 2026 — could provide a meaningful boost to unhedged international equity returns.

On the risk side, an escalation or prolonged duration of the Middle East energy supply disruption could dampen global growth, pressure corporate margins in energy-sensitive sectors, and reignite inflation concerns — all of which would challenge international equity performance. Japan's evolving monetary policy stance, given the fund's substantial allocation to Japanese equities, also warrants close monitoring. Finally, as international equities continue to attract capital flows, the competitive landscape among international equity ETFs may intensify, making MFDX's factor-based methodology and expense ratio important differentiators for cost-conscious investors.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MFDX

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


Momentum Indicator for MFDX turns positive, indicating new upward trend

MFDX saw its Momentum Indicator move above the 0 level on July 30, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned positive. In of the 81 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 55 cases where MFDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MFDX just turned positive on July 30, 2026. Looking at past instances where MFDX's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

MFDX moved above its 50-day moving average on July 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MFDX crossed bullishly above the 50-day moving average on August 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MFDX advanced for three days, in of 336 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 325 cases where MFDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MFDX moved out of overbought territory on August 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 51 similar instances where the indicator moved out of overbought territory. In of the 51 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MFDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MFDX broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are Merck & Co (NYSE:MRK), AstraZeneca PLC (NYSE:AZN), BHP Group Limited (NYSE:BHP), Shopify Inc (NASDAQ:SHOP), AT&T (NYSE:T), Boeing Company (NYSE:BA), Medtronic plc (NYSE:MDT), BP plc (NYSE:BP), Spotify Technology SA (NYSE:SPOT), Suncor Energy (NYSE:SU).

Industry description

The investment seeks to track the investment results of the RAFI Dynamic Multi-Factor Developed Ex-U.S. Index. The fund seeks to achieve its investment objective by investing at least 80% of its total assets (exclusive of collateral held from securities lending) in the component securities of the RAFI Dynamic Multi-Factor Developed Ex-U.S. Index. The underlying index is constructed by the index provider using a rules-based approach to construct factor portfolios within the underlying index. The underlying index consists of "factor portfolios," each of which emphasizes one of the following factors: value, low volatility, quality, momentum and size.

Market Cap

The average market capitalization across the PIMCO RAFI Dyn Multi-Factor Intl Eq ETF ETF is 41.44B. The market cap for tickers in the group ranges from 989.57K to 676.06B. ASML holds the highest valuation in this group at 676.06B. The lowest valued company is ANDR at 989.57K.

High and low price notable news

The average weekly price growth across all stocks in the PIMCO RAFI Dyn Multi-Factor Intl Eq ETF ETF was 70%. For the same ETF, the average monthly price growth was 97%, and the average quarterly price growth was 652%. AU experienced the highest price growth at 27%, while TE experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the PIMCO RAFI Dyn Multi-Factor Intl Eq ETF ETF was 11%. For the same stocks of the ETF, the average monthly volume growth was -29% and the average quarterly volume growth was -20%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 56
Price Growth Rating: 48
SMR Rating: 62
Profit Risk Rating: 63
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
MFDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category ForeignLargeBlend

Profile
Details
Category
Foreign Large Blend
Address
PIMCO Equity Series650 Newport Center DriveNewport Beach
Phone
N/A
Web
www.pimco.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.